{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T01:03:16Z","timestamp":1760317396761,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41379-022-01126-3","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T02:02:35Z","timestamp":1660528955000},"page":"1618-1623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma"],"prefix":"10.1016","volume":"35","author":[{"given":"Matthew","family":"Margolis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Janovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Laird","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas A.","family":"Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9155-556X","authenticated-orcid":false,"given":"Meagan","family":"Montesion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7838-2526","authenticated-orcid":false,"given":"Russell W.","family":"Madison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa B.","family":"Schrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Tukachinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Erlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Hiemenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.P.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Elvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Anne","family":"Vergilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0105-9760","authenticated-orcid":false,"given":"Douglas I.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-2596","authenticated-orcid":false,"given":"Jeffrey","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Oxnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brennan","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01126-3_bib1","doi-asserted-by":"crossref","unstructured":"Ellington, C. L., Goodman, M., Kono, S. A., Grist, W., Wadsworth, T., Chen, A. Y. et al. Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data. Cancer118, 4444\u20134451 (2012).","DOI":"10.1002\/cncr.27408"},{"key":"10.1038\/s41379-022-01126-3_bib2","doi-asserted-by":"crossref","unstructured":"Chen, J. C., Gnepp, D. R. & Bedrossian, C. W. Adenoid cystic carcinoma of the salivary glands: an immunohistochemical analysis. Oral Surg Oral Med Oral Pathol65, 316\u2013326 (1988).","DOI":"10.1016\/0030-4220(88)90116-8"},{"key":"10.1038\/s41379-022-01126-3_bib3","doi-asserted-by":"crossref","unstructured":"Szanto, P. A., Luna, M. A., Tortoledo, M. E. & White, R. A. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer54, 1062\u20131069 (1984).","DOI":"10.1002\/1097-0142(19840915)54:6<1062::AID-CNCR2820540622>3.0.CO;2-E"},{"key":"10.1038\/s41379-022-01126-3_bib4","doi-asserted-by":"crossref","unstructured":"Cheng, J., Saku, T., Okabe, H. & Furthmayr, H. Basement membranes in adenoid cystic carcinoma. An immunohistochemical study. Cancer69, 2631\u20132640 (1992).","DOI":"10.1002\/1097-0142(19920601)69:11<2631::AID-CNCR2820691103>3.0.CO;2-P"},{"key":"10.1038\/s41379-022-01126-3_bib5","doi-asserted-by":"crossref","unstructured":"Seethala, R. R. Basaloid\/blue salivary gland tumors. Mod Pathol30, S84\u2013S95 (2017).","DOI":"10.1038\/modpathol.2016.190"},{"key":"10.1038\/s41379-022-01126-3_bib6","doi-asserted-by":"crossref","unstructured":"Ho, A. S., Ochoa, A., Jayakumaran, G., Zehir, A., Valero Mayor, C., Tepe, J. et al. Genetic hallmarks of recurrent\/metastatic adenoid cystic carcinoma. J Clin Invest129, 4276\u20134289 (2019).","DOI":"10.1172\/JCI128227"},{"key":"10.1038\/s41379-022-01126-3_bib7","doi-asserted-by":"crossref","unstructured":"Persson, M., Andr\u00e9n, Y., Mark, J., Horlings, H. M., Persson, F. & Stenman, G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA106, 18740\u201318744 (2009).","DOI":"10.1073\/pnas.0909114106"},{"key":"10.1038\/s41379-022-01126-3_bib8","doi-asserted-by":"crossref","unstructured":"Mitani, Y., Liu, B., Rao, P. H., Borra, V. J., Zafereo, M., Weber, R. S. et al. Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations. Clin Cancer Res22, 725\u2013733 (2016).","DOI":"10.1158\/1078-0432.CCR-15-2867-T"},{"key":"10.1038\/s41379-022-01126-3_bib9","doi-asserted-by":"crossref","unstructured":"Ferrarotto, R., Mitani, Y., Diao, L., Guijarro, I., Wang, J., Zweidler-McKay, P. et al. Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to notch1 inhibitors. J Clin Oncol35, 352\u2013360 (2017).","DOI":"10.1200\/JCO.2016.67.5264"},{"key":"10.1038\/s41379-022-01126-3_bib10","doi-asserted-by":"crossref","unstructured":"Molloy, C. J., Gallo, M. A. & Laskin, J. D. Alterations in the expression of specific epidermal keratin markers in the hairless mouse by the topical application of the tumor promoters 2,3,7,8-tetrachlorodibenzo-p-dioxin and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis8, 1193\u20131199 (1987).","DOI":"10.1093\/carcin\/8.9.1193"},{"key":"10.1038\/s41379-022-01126-3_bib11","doi-asserted-by":"crossref","unstructured":"Andersson, M. K., Afshari, M. K., Andr\u00e9n, Y., Wick, M. J. & Stenman, G. Targeting the oncogenic transcriptional regulator MYB in adenoid cystic carcinoma by inhibition of IGF1R\/AKT signaling. J Natl Cancer Inst109, (2017).","DOI":"10.1093\/jnci\/djx017"},{"key":"10.1038\/s41379-022-01126-3_bib12","doi-asserted-by":"crossref","unstructured":"Andersson, M. K., \u00c5man, P. & Stenman, G. IGF2\/IGF1R signaling as a therapeutic target in MYB-positive adenoid cystic carcinomas and other fusion gene-driven tumors. Cells8, E913 (2019).","DOI":"10.3390\/cells8080913"},{"key":"10.1038\/s41379-022-01126-3_bib13","doi-asserted-by":"crossref","unstructured":"Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal6, pl1 (2013).","DOI":"10.1126\/scisignal.2004088"},{"key":"10.1038\/s41379-022-01126-3_bib14","doi-asserted-by":"crossref","unstructured":"Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov2, 401\u2013404 (2012).","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"10.1038\/s41379-022-01126-3_bib15","doi-asserted-by":"crossref","unstructured":"Frampton, G. M., Fichtenholtz, A., Otto, G. A., Wang, K., Downing, S. R., He, J. et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol31, 1023\u20131031 (2013).","DOI":"10.1038\/nbt.2696"},{"key":"10.1038\/s41379-022-01126-3_bib16","unstructured":"Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R. et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med23, 703\u2013713 (2017)."},{"key":"10.1038\/s41379-022-01126-3_bib17","doi-asserted-by":"crossref","unstructured":"Li, J., Choi, E., Yu, H. & Bai, X.-C. Structural basis of the activation of type 1 insulin-like growth factor receptor. Nat Commun10, 4567 (2019).","DOI":"10.1038\/s41467-019-12564-0"},{"key":"10.1038\/s41379-022-01126-3_bib18","doi-asserted-by":"crossref","unstructured":"Yasuda, H., Park, E., Yun, C.-H., Sng, N. J., Lucena-Araujo, A. R., Yeo, W.-L. et al. Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer. Sci Transl Med5, 216ra177 (2013).","DOI":"10.1126\/scitranslmed.3007205"},{"key":"10.1038\/s41379-022-01126-3_bib19","doi-asserted-by":"crossref","unstructured":"Chakraborty, A. K., Zerillo, C. & DiGiovanna, M. P. In vitro and in vivo studies of the combination of IGF1R inhibitor figitumumab (CP-751,871) with HER2 inhibitors trastuzumab and neratinib. Breast Cancer Res Treat152, 533\u2013544 (2015).","DOI":"10.1007\/s10549-015-3504-2"},{"key":"10.1038\/s41379-022-01126-3_bib20","doi-asserted-by":"crossref","unstructured":"Neuzillet, Y., Chapeaublanc, E., Krucker, C., De Koning, L., Lebret, T., Radvanyi, F. et al. IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer. BMC Cancer17, 636 (2017).","DOI":"10.1186\/s12885-017-3618-5"},{"key":"10.1038\/s41379-022-01126-3_bib21","doi-asserted-by":"crossref","unstructured":"Fassnacht, M., Berruti, A., Baudin, E., Demeure, M. J., Gilbert, J., Haak, H. et al. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. Lancet Oncol16, 426\u2013435 (2015).","DOI":"10.1016\/S1470-2045(15)70081-1"},{"key":"10.1038\/s41379-022-01126-3_bib22","doi-asserted-by":"crossref","unstructured":"Schmitz, S., Kaminsky-Forrett, M.-C., Henry, S., Zanetta, S., Geoffrois, L., Bompas, E. et al. Phase II study of figitumumab in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02). Ann Oncol23, 2153\u20132161 (2012).","DOI":"10.1093\/annonc\/mdr574"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01126-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01126-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01126-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:40:36Z","timestamp":1760229636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222002289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0893395222002289"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01126-3","relation":{},"ISSN":["0893-3952"],"issn-type":[{"type":"print","value":"0893-3952"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01126-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}